EP3226842
Krabbameinshemjandi samsetningar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.12.2015EP published:
25.11.2020EP application number:
15817642.0
EP translation filed:
20.1.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
2.12.2035Expiry date:
2.12.2023
Title:
ANTICANCER COMPOSITIONS
Timeline
Today
3.12.2015EP application
25.11.2020EP Publication
20.1.2021Translation submitted
15.2.2021Registration published
2.12.2023Expires
Owner
Name:
Aragon Pharmaceuticals, Inc.Address:
10990 Wilshire Blvd, Suite 300, Los Angeles, CA 90024, US
Inventor
Name:
VERRECK, GeertAddress:
2340 Beerse, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
14196591Date:
5.12.2014Country:
EP
Classification
Categories:
A61K 9/14, A61K 9/20, A61P 13/08, A61P 35/00, A61P 35/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.1.2021
Expires: 2.12.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.11.2021
Expires: 2.12.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.11.2022
Expires: 2.12.2023
Payer: Árnason Faktor ehf.